Literature DB >> 1987955

Autosomal dominant sectoral retinitis pigmentosa. Two families with transversion mutation in codon 23 of rhodopsin.

J R Heckenlively1, J A Rodriguez, S P Daiger.   

Abstract

A cytosine-to-adenine transversion in codon 23 of rhodopsin, the rod visual pigment gene, was reported recently by Dryja et al in 17 of 148 unrelated patients with autosomal dominant retinitis pigmentosa, but the clinical findings associated with this deletion have not been reported in detail. In screening our patients with autosomal dominant retinitis pigmentosa for the codon 23 transversion, we found positive results in four affected individuals from two families with sectoral retinitis pigmentosa, while 12 patients with sectoral retinitis pigmentosa from different families had negative results, suggesting that other gene sites or locations may give this same phenotypic change. From our patients' history of light exposure and the location of degeneration in the retina, we hypothesize that light phototoxicity may be playing an expressive role in this point mutation of the rhodopsin gene. This is the first report in which a type of retinitis pigmentosa has been associated with a specific molecular gene defect, although the actual pathophysiologic mechanism currently is unknown.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1987955     DOI: 10.1001/archopht.1991.01080010086038

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  56 in total

Review 1.  Molecular ophthalmology: an update on animal models for retinal degenerations and dystrophies.

Authors:  F Hafezi; C Grimm; B C Simmen; A Wenzel; C E Remé
Journal:  Br J Ophthalmol       Date:  2000-08       Impact factor: 4.638

2.  Nine generations of a family with autosomal dominant retinitis pigmentosa and evidence of variable expressivity from census records.

Authors:  M Jay; A C Bird; A N Moore; B Jay
Journal:  J Med Genet       Date:  1992-12       Impact factor: 6.318

3.  Sector Retinitis Pigmentosa caused by mutations of the RHO gene.

Authors:  Ting Xiao; Ke Xu; Xiaohui Zhang; Yue Xie; Yang Li
Journal:  Eye (Lond)       Date:  2018-11-02       Impact factor: 3.775

4.  Ocular findings in patients with autosomal dominant retinitis pigmentosa and Cys110Phe, Arg135Gly, and Gln344stop mutations of rhodopsin.

Authors:  S Kremmer; A Eckstein; A Gal; E Apfelstedt-Sylla; H Wedemann; K Rüther; E Zrenner
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1997-09       Impact factor: 3.117

Review 5.  Light and inherited retinal degeneration.

Authors:  D M Paskowitz; M M LaVail; J L Duncan
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

6.  Bisretinoids mediate light sensitivity resulting in photoreceptor cell degeneration in mice lacking the receptor tyrosine kinase Mer.

Authors:  Jin Zhao; Keiko Ueda; Marina Riera; Hye Jin Kim; Janet R Sparrow
Journal:  J Biol Chem       Date:  2018-10-23       Impact factor: 5.157

7.  Retinal laminar architecture in human retinitis pigmentosa caused by Rhodopsin gene mutations.

Authors:  Tomas S Aleman; Artur V Cideciyan; Alexander Sumaroka; Elizabeth A M Windsor; Waldo Herrera; D Alan White; Shalesh Kaushal; Anjani Naidu; Alejandro J Roman; Sharon B Schwartz; Edwin M Stone; Samuel G Jacobson
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-04       Impact factor: 4.799

8.  Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase beta subunit.

Authors:  J Lem; J G Flannery; T Li; M L Applebury; D B Farber; M I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-15       Impact factor: 11.205

Review 9.  Finding and interpreting genetic variations that are important to ophthalmologists.

Authors:  Edwin M Stone
Journal:  Trans Am Ophthalmol Soc       Date:  2003

10.  Increased light exposure alleviates one form of photoreceptor degeneration marked by elevated calcium in the dark.

Authors:  Xiaoqing Liu; Basil S Pawlyk; Michael Adamian; Elena V Olshevskaya; Alexander M Dizhoor; Clint L Makino; Tiansen Li
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.